Remdesivir Did Not Reduce Hospital Stay, Mortality In COVID Patients: WHO

By
OB Bureau

New Delhi: Gilead Sciences Inc’s remdesivir had little or no effect on the length of hospital stay of COVID patients or their chances of survival, a clinical trial by the World Health Organization (WHO) has found, NDTV reported.

The antiviral medication, among the first to be used as a treatment for COVID-19, was one of the drugs recently used to treat U.S. President Donald Trump’s coronavirus infection, the report added.

WHO carried out a “Solidarity” trial to evaluate the effects of four potential drug regimens, including remdesivir, hydroxychloroquine, anti-HIV drug combination lopinavir/ritonavir and interferon, in 11,266 adult patients across more than 30 countries.

According to the study, the regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital course among patients hospitalised with COVID-19. The results of the trial are yet to be reviewed and were uploaded on the preprint server medRxiv.

“The emerging (WHO) data appears inconsistent, with more robust evidence from multiple randomized, controlled studies published in peer-reviewed journals validating the clinical benefit of remdesivir,” Gilead told Reuters.

What doctors say

Dr Anupam Singh in Ghaziabad who has been treating COVID-19 patients pointed out that the message from the trial is that antivirals will work only at viremia stage (when the virus enters the bloodstream) and not at inflammatory stage or post 6-7 days of disease onset, The New Indian Express (TNIE) reported.

Most of the patients in India seek hospitalisation, only in the inflammatory stage.

He also told TNIE that while there is discordance among the US and Solidarity trials regarding remdesivir, there is a signal of benefit in all patients given remdesivir in low-risk stages such as those not on a ventilator or high flow oxygen.

“Remdesivir is likely to be useless once patient presents in high-risk stage,” he said.

OB Bureau

Recent Posts

Youth Critically Injured In Sword Attack In Bhubaneswar

Bhubaneswar: A youth was critically injured reportedly in an armed attack by some miscreants in…

April 27, 2024

‘Not My Wife Anymore’: Man Tries To Kill Woman After Brother Rapes Her

Lucknow: Imagine a man trying to kill his wife because she confided in him that she…

April 27, 2024

Lightning During Northwesterly Claims 2 More Lives In Odisha’s Kendrapada

Kendrapada: Lightning strike during northwesterly killed two more persons including a woman in Odisha's Kendrapada district…

April 27, 2024

Sunita Roadshow: ‘Arvind Kejriwal Is A Sher, Nobody Can Break Him’

New Delhi: More than five weeks after being arrested by Enforcement Directorate, Arvind Kejriwal has not…

April 27, 2024

Odisha Polls: Chhattisgarh CM & Ex-Tripura CM Add Muscle To BJP Campaign

Bhubaneswar: With BJD president and Chief Minister Naveen Patnaik taking the lead in kicking off…

April 27, 2024

Undelivered Ice Cream: Consumer Court Orders Swiggy To Pay Customer Rs 5,000

Bengaluru: A consumer court here has ordered Swiggy to pay Rs 3,000 as compensation and…

April 27, 2024

Book On 100 Great IIT-ians To Be Released At Bhubaneswar’s SOA

Bhubaneswar: What is common between Nandan Nilekani, Kota Harinarayana, Narayana Murthy, Damodar Acharya, BK Syngal,…

April 27, 2024

Odisha Assembly Polls: OPCC Recommends Sofia Firdous’ Name For Cuttack-Barabati To AICC

Bhubaneswar: The Odisha Pradesh Congress Committee (OPCC) has proposed to AICC for nominating Sofia Firdous…

April 27, 2024